Sovereign Nations. Different Laws. One Complicated Payments System.
Sovereign Nations. Different Laws. One Complicated Payments System. On Indigenous Peoples' Day, it's time to examine why tribal gaming, ...
Veterinary practices across the United States may be unknowingly violating federal child safety laws when dispensing prescription medications in envelopes, plastic bags, or manufacturer packaging that lacks child-resistant features. Sarah Magoon, a Licensed Veterinary Technician and Practice Consultant Manager for the American Animal Hospital Association (AAHA), identifies this as a widespread compliance issue discovered during virtually every accreditation evaluation.
The Poison Prevention Packaging Act (PPPA), enforced by the Consumer Product Safety Commission (CPSC), mandates that prescription drugs in oral dosage form be dispensed in "special packaging" designed to be significantly difficult for children under 5 years of age to open within a reasonable time while not difficult for adults to use properly. This federal requirement applies to veterinary medications just as it does to human pharmaceuticals.
Philip J. Seibert, Jr., CVT, founder of Safety Vet and former AAHA practice consultant, emphasizes that liability shifts from the manufacturer to the veterinary practice when the original packaging is altered. "If the practice removes or alters any of the manufacturer's original packaging prior to dispensing, then the practice now assumes all responsibility for ensuring compliance with the child-proof packaging rules," Seibert explained.
Magoon identifies three scenarios where practices most frequently fail to meet child-resistant packaging requirements. First, pre-drawn syringes of liquid medication sent home in plastic resealable bags lack any child-resistant features despite containing potentially dangerous substances. Second, antibiotic tablets packed in foil dispensed in manufacturer envelopes or bags do not meet PPPA standards, even when those envelopes come from drug companies. Third, parasite prevention boxes opened to dispense individual doses of heartworm or flea and tick medication in manufacturer envelopes or plastic bags violate federal requirements.
The confusion often stems from manufacturer-provided packaging that appears designed for individual-dose dispensing but serves only informational purposes. These materials do not meet PPPA standards for special packaging, regardless of their professional appearance or pharmaceutical company branding.
Veterinary practices have several options for achieving PPPA compliance with products that don't fit standard pill vials. Larger pill vials—60-dram or larger according to Magoon—can accommodate pre-drawn syringes, strips of blister-packed tablets, and single doses of parasite prevention in their original foil packaging. These containers feature child-resistant closures that require actions such as "push down and turn" or "squeeze and turn" and meet federal standards.
Child-resistant dispensing bags offer another compliant solution, particularly for awkwardly shaped items. These bags require a sequence of steps to open that would be difficult for young children while remaining manageable for adults. Some bags are single-use only, appropriate for individual parasite prevention doses, while others can be opened and closed repeatedly for medications requiring daily administration.
Magoon notes these bags are used across human pharmacy, veterinary medicine, and marijuana dispensing. Practices sourcing bags from non-veterinary distributors must ensure they don't contain marijuana warnings inappropriate for veterinary use.
Child-resistant packaging can create challenges for senior pet owners and clients with limited dexterity. However, some solutions remain accessible to these populations while maintaining child safety. Pop-top lids that release with heel-of-hand pressure make opening easier for those with arthritis or limited grip strength, while remaining difficult for young children.
Clients can also decline child-resistant packaging with informed consent, allowing practices to dispense medications in easier-to-open containers. This waiver must be documented in the medical record, with requirements varying by state. Some jurisdictions require signed forms acknowledging CRP decline, while others accept notation in patient records. Magoon recommends creating invoice line items indicating CRP declination so clients see the notation on every transaction.
Importantly, clients must decline CRP each time medication is dispensed, unless they request a "blanket waiver" for all prescriptions. Even with blanket waivers, the CPSC recommends periodic confirmation that clients still wish to decline child-resistant packaging.
Practice leaders with questions about PPPA-compliant dispensing can consult the CPSC's Guide for Healthcare Professionals. AAHA-accredited practices receive guidance from practice consultants during evaluation processes, helping identify and remediate compliance gaps before they result in regulatory enforcement or, worse, child poisoning incidents.
Subscribe to Our Newsletter
Stay informed with daily insights on compliance, regulation, and industry trends affecting highly regulated industries.
Subscribe Here
Read Our Blog
Explore in-depth analysis and expert perspectives on navigating the complex regulatory landscape for hemp, CBD, and botanical products.
Visit Our Blog
Reach Out to Learn More About Our Products
Discover how Q-Trust can strengthen your compliance framework, adapt to rapid regulatory changes, and protect your business from federal and state enforcement actions.
Contact Us
